Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan
NCT03143166
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG:
Dabigatran Etexilate
DRUG:
Rabeprazol sodium
Sponsor
Boehringer Ingelheim